Related Experiment Videos

Mutagenic virus replication in human tumor cells

Cancer Letters
|November 1, 1982
PubMed

Insights

Human tumor cells increase herpes simplex virus mutation rates. Virus grown in tumor cell lines showed higher iododeoxycytidine resistance, indicating increased mutagenicity compared to normal cells.

Area of Science:

  • Virology
  • Cancer Cell Biology
  • Genetics

Background:

  • Herpes simplex virus (HSV) is a common human pathogen.
  • Understanding viral replication and mutation is crucial for disease control.
  • Tumor cells may possess unique properties influencing viral behavior.

Purpose of the Study:

  • To investigate the mutagenic potential of herpes simplex virus replication in human tumor cells versus normal cells.
  • To determine if human tumor cell lines enhance viral mutation rates.

Main Methods:

  • Herpes simplex virus was cultured in various human tumor and normal cell lines.
  • Progeny virus was tested for resistance to iododeoxycytidine, a marker for viral genome mutations.
  • Mutation frequencies were compared between virus grown in tumor cells and normal cells.

Main Results:

  • Virus propagated in 4 out of 5 human tumor cell lines exhibited significantly higher fractions of iododeoxycytidine resistance compared to virus grown in 7 normal human skin cell lines.
  • In two osteosarcoma patient cases, tumor cells showed enhanced mutagenesis, while their normal skin fibroblasts did not.
  • These findings suggest a mutagenic effect of certain tumor cell environments on herpes simplex virus.

Conclusions:

  • Some human tumor cell lines can alter the herpesvirus replication process, leading to increased mutagenicity.
  • This phenomenon may have implications for understanding virus-tumor interactions and potential therapeutic strategies.

Related Concept Videos